Fresh analysis reveals that people who stop using new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who end conventional lifestyle plans.
Published data in a prominent health publication points out that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of nearly a kilo each month after stopping.
"People purchasing such drugs should be informed of the potential of fast rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to starting mass within about a year and a half.
Analyzing Approaches
The study, which reviewed dozens of studies involving thousands of participants, contrasted the results of the injectable medications with other pills.
Scientists emphasize that individuals who shed pounds through dieting usually see a less rapid weight regain—around 0.1 kg a month—after stopping.
Explaining the Rapid Regain
Nutrition scientists believe the mode of action of the injections is key to understanding the accelerated weight return.
These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement leads to hunger is unsuppressed, making overeating a significant risk."
A Lifelong Disease?
Medical guidelines recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.
Many experts contend that, considering the likelihood of weight regain, the treatment might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who say that the results "highlight the persistent nature of obesity," comparing it to managing conditions like diabetes.
Patient Experiences
People who have discontinued the jabs explain a sudden resurgence of cravings.
"It was like a switch activating and you become extremely hungry," recalled a patient.
This difficulty is worsened if individuals have not developed permanent lifestyle or habit modifications during therapy.
Significant Adoption
Survey data indicate that millions of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.
- Use is more common among women than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are potent agents for shedding pounds, they are not a permanent fix and maintained weight loss hinges on ongoing lifestyle support.
